Skip to content

Clinical trials

Terminated Phase 2 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 2 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20081
20092
20111
20121
20131
20151
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital1
Canopy Growth Corporation1
Christian Haslinger1
Insel Gruppe AG, University Hospital Bern1
Mayo Clinic1
Mclean Hospital1
National Center for Complementary and Integrative Health (NCCIH)1
National Institute of Mental Health (NIMH)1
National Institute of Neurological Disorders and Stroke (NINDS)1
Rambam Health Care Campus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders13
Neoplasms2
Bipolar Disorder1
Epilepsies, Partial1
Epilepsy1
Epilepsy, Temporal Lobe1
Mania1
Obstetric Labor, Premature1
Pain1
Phobic Disorders1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.